Studies have shown that AKR1B10 can induce a variety of cancers, such as liver cancer (25), non-small cell lung cancer (26), and pancreatic cancer (27), and represents a promising potential cancer target. The gene discussed is AKR1B10; the disease is familial pancreatic carcinoma.